Your browser doesn't support javascript.
loading
Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.
Sachdeva, Kuldeep Singh; Raizada, Neeraj; Sreenivas, Achuthan; Van't Hoog, Anna H; van den Hof, Susan; Dewan, Puneet K; Thakur, Rahul; Gupta, R S; Kulsange, Shubhangi; Vadera, Bhavin; Babre, Ameet; Gray, Christen; Parmar, Malik; Ghedia, Mayank; Ramachandran, Ranjani; Alavadi, Umesh; Arinaminpathy, Nimalan; Denkinger, Claudia; Boehme, Catharina; Paramasivan, C N.
Afiliación
  • Sachdeva KS; Central TB Division, Government of India, New Delhi, India.
  • Raizada N; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
  • Sreenivas A; World Health Organization, India Country Office, New Delhi, India.
  • Van't Hoog AH; Department of Global Health, Academic Medical Center and Amsterdam Institute of Global Health and Development, Amsterdam, The Netherlands.
  • van den Hof S; Department of Global Health, Academic Medical Center and Amsterdam Institute of Global Health and Development, Amsterdam, The Netherlands; KNCV Tuberculosis Foundation, The Hague, The Netherlands.
  • Dewan PK; World Health Organization, India Country Office, New Delhi, India.
  • Thakur R; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
  • Gupta RS; Central TB Division, Government of India, New Delhi, India.
  • Kulsange S; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
  • Vadera B; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
  • Babre A; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
  • Gray C; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
  • Parmar M; World Health Organization, India Country Office, New Delhi, India.
  • Ghedia M; Central TB Division, Government of India, New Delhi, India.
  • Ramachandran R; World Health Organization, India Country Office, New Delhi, India.
  • Alavadi U; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
  • Arinaminpathy N; Department of Infectious Disease Epidemiology, School of Public Health, Imperial College, London, United Kingdom.
  • Denkinger C; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
  • Boehme C; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
  • Paramasivan CN; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
PLoS One ; 10(5): e0126065, 2015.
Article en En | MEDLINE | ID: mdl-25996389
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tuberculosis Pulmonar / Tuberculosis Resistente a Múltiples Medicamentos / Técnicas de Diagnóstico Molecular / Vigilancia en Salud Pública Tipo de estudio: Diagnostic_studies / Prognostic_studies País/Región como asunto: Asia Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tuberculosis Pulmonar / Tuberculosis Resistente a Múltiples Medicamentos / Técnicas de Diagnóstico Molecular / Vigilancia en Salud Pública Tipo de estudio: Diagnostic_studies / Prognostic_studies País/Región como asunto: Asia Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article